Navigation Links
Tosoh Bioscience LLC invests in Semba Biosciences
Date:11/29/2018

Tosoh Bioscience LLC announced it has completed an equity investment in Semba Biosciences with the intention of acquiring full ownership. The transaction was approved by the Board of Directors of both companies and an Equity Participation Agreement was executed on November 14, 2018. “We are extremely pleased to team up with Tosoh Bioscience to offer customers the most advanced platform for multicolumn continuous biochromatography. Our respective technologies fit perfectly together to provide an integrated solution for bioprocess research, development and continuous manufacturing”, said Dr. Robert Mierendorf, President of Semba Biosciences. The two companies have been collaborating on various downstream biomanufacturing projects since 2007. According to Ali Soleymannezhad, Director of Sales and Marketing at Tosoh Bioscience, “by combining Semba Biosciences’ advanced Simulated Moving Bed (SMB) technology with Tosoh Bioscience’s best-in-class resins, we will be able to offer the most productive and the most efficient solution in bioprocess chromatography while maintaining the highest quality”. He added, “We are excited to work with Semba Biosciences’ experts to extend the boundaries of downstream biopurification and set a new benchmark in the industry.”

TOSOH BIOSCIENCE LLC
Tosoh Bioscience LLC provides liquid chromatography products to laboratories and manufacturing plants in the Americas. While the majority of our customers work in biotechnology and pharmaceutical companies, our U/HPLC columns and systems are essential tools for sample analysis in most industries. Our all-in-one dedicated GPC system, the EcoSEC GPC System, is predominantly used in the chemical and polymer industries while our EcoSEC High Temperature GPC System is ideal for the polyolefin and oil industries. In the field of biotechnology, our preparative chromatography resins play a critical role in the purification of proteins and nucleic acids for medical purposes.

The company is a subsidiary of Tosoh Corporation in Japan, the parent of the Tosoh Group, which comprises over 100 companies worldwide and a multiethnic workforce of over 12,000 people and generated sales of ¥822.9 billion (US $7.4 billion at the average rate of ¥100.85 to the US dollar) in fiscal 2018, ended March 31, 2018.

SEMBA BIOSCIENCES, INC.
Semba Biosciences is a life science company based in Madison, Wisconsin, USA. Founded in 2005, the company pioneered the development of bench top continuous chromatography systems for efficient and scalable purification of biomolecules. Today the company’s lab-scale Octave® Systems are used in the food, chemical, and pharmaceutical industries worldwide. The new ProPD™ and ProGMP™ products bring the power of continuous chromatography to the biopharmaceutical industry for downstream process development and single-use manufacturing.

Read the full story at https://www.prweb.com/releases/tosoh_bioscience_llc_invests_in_semba_biosciences/prweb15955419.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. ACEA Biosciences Launches xCELLigence® RTCA Software Pro to Further Enhance Immuno-Oncology Experimental Design and Analysis
2. ACEA Biosciences Releases New Version of NovoExpress® Flow Cytometry Software.
3. ACEA Biosciences Introduces an Exploratory xCELLigence® RTCA S16 Instrument
4. Pressure BioSciences Closes Additional $745,000 of $5 Million PIPE; Funding Received to Date Exceeds $4,000,000
5. New bilateral pilot opportunity will fund collaborations between US and UK bioscience researchers
6. The new Africa -- green shoots in biosciences
7. Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
8. Wellspring Biosciences Founder Publishes In Nature On Discovery of Small Molecule Inhibitors of K-Ras
9. AlloSource Named One Of Colorados Top Bioscience Companies Of The Year
10. Springer will publish lecture series with the Mathematical Biosciences Institute
11. Oxford University Press to publish BioScience journal from 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2019)... ... May 30, 2019 , ... Researchers from Ambry Genetics ... significant differences in the prevalence of hereditary genetic mutations, also called germline mutations, ... women. Results will be presented at the 2019 American Society of Clinical Oncology ...
(Date:5/24/2019)... ... , ... The newest edition of Crystallography Times from Rigaku ... , Crystallography Times is a monthly electronic newsletter published by Rigaku Oxford Diffraction ( ... by presenting the latest news and crystallographic research. , “Crystallography in the News” ...
(Date:5/21/2019)... ... May 21, 2019 , ... If a ... know? How can we tell it apart from the millions of microorganisms that ... multi-institution research team, including Eric Young , assistant professor of chemical engineering ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... 2019 , ... Veterinary Regenerative Medicine company, VetStem Biopharma ... that their GMP facility for cell production is now approved by the California ... an important milestone for VetStem as it expands into contract cell manufacturing services. ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... the USPTO providing proprietary interest to our methodology, processes, and diagnostic techniques. ... AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep scoring methodology. ...
(Date:5/22/2019)... (PRWEB) , ... May 22, 2019 , ... Artemis ... closed a $8 million Series A funding round co-led by Astanor Ventures ... Empire State Development Fund and iSelect Fund . The company has raised ...
(Date:5/14/2019)... ... May 13, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries’ is excited to announce the go-live ... LDA’s ability to communicate directly with the marketplace; serving as a destination to ...
Breaking Biology Technology: